ホーム › 悪性黒色腫 › カリフォルニア州 › Orange
Orange、CAにおける悪性黒色腫の臨床試験
Orangeとその周辺地域（約30マイル以内）の拠点で、悪性黒色腫に関する14件の研究が参加者を募集しています。研究を開いて、参加資格と連絡方法を確認してください。
公式研究テキスト（英語）
ここで研究参加者を募集していますか？ このページの上部に表示できます — 30日間 $99 →
BiCaZO: A Study Combining Two Immunotherapies (Cabozantinib and Nivolumab) to Treat Patients With Advanced Melanoma or Squamous Cell Head and Neck Cancer, an immunoMATCH Pilot Study
被験者募集中第2相
- UC Irvine Health/Chao Family Comprehensive Cancer Center, Orange
A Study With Combinations of Anti-LAG-3 and Anti-PD-1 Antibodies in Adult Participants With Advanced or Metastatic Melanoma (Harmony Head-to-Head)
被験者募集中第3相
- St. Joseph Hospital Orange, Orange
- University of California Irvine, UCI Medical Center, Orange
Comparing the Effectiveness of Less Invasive Procedures With the Current Standard of Care for the Treatment of Older Adults With Early-Stage Melanoma
被験者募集中第3相
- UC Irvine Health/Chao Family Comprehensive Cancer Center, Orange
Tegavivint for the Treatment of Recurrent or Refractory Solid Tumors, Including Lymphomas and Desmoid Tumors
被験者募集中第1/2相
- Children's Hospital of Orange County, Orange
Project: Every Child for Younger Patients With Cancer
被験者募集中観察研究
- Children's Hospital of Orange County, Orange
Feasibility Study on the Effect of a Methionine-Reduced Diet on Serum Levels in Pts w/ Solid Tumors
被験者募集中早期第1相
- Chao Family Comprehensive Cancer Center, University of California, Irvine, Orange
Repurposing Riluzole for Cancer-Related Cognitive Impairment: A Pilot Trial
被験者募集中第2相
- Chao Family Comprehensive Cancer Center, University of California Irvine, Orange
MC1R-targeted Alpha-particle Monotherapy and Combination Therapy Trial With Nivolumab in Adults With Advanced Melanoma
被験者募集中第1/2相
- University of California Irvine, Orange
Study of RMC-6236 in Patients With Advanced Solid Tumors Harboring Specific Mutations in RAS
被験者募集中第1/2相
- UC Irvine/Chao Family Comprehensive Cancer Center, Orange
Neoadjuvant Darovasertib in Primary Uveal Melanoma
被験者募集中第3相
- University of California Irvine Medical Center, Orange
A Study of VET3-TGI in Patients With Solid Tumors
被験者募集中第1相
- UC Irvine Health, Orange
Metronomic Cyclophosphamide With Pembrolizumab in Checkpoint Inhibitor Refractory Melanoma
被験者募集中第2相
- Chao Family Comprehensive Cancer Center University of California, Irvine, Orange
SYNERGY-AI: Artificial Intelligence Based Precision Oncology Clinical Trial Matching and Registry
被験者募集中観察研究
- Massive Bio SYNERGY-AI site, Orange
Melanoma Margins Trial-II: 1cm v 2cm Wide Surgical Excision Margins for AJCC Stage II Primary Cutaneous Melanoma
被験者募集中
- UC Irvine Health - Chao Family Comprehensive Cancer Center, Orange
- UCI Health - Chao Family Comprehensive Cancer Center and Ambulatory Care, Orange
他の都市における悪性黒色腫の試験
- Houston, TX59件の研究
- New York City, NY38件の研究
- Los Angeles, CA34件の研究
- Nashville, TN33件の研究
- Pittsburgh, PA31件の研究
- Boston, MA26件の研究
- Philadelphia, PA23件の研究
- San Francisco, CA22件の研究
- Durham, NC21件の研究
- Atlanta, GA21件の研究
- St. Louis, MO21件の研究
- Salt Lake City, UT21件の研究
Orangeにおける他の研究
- 非小細胞肺癌25件の研究
- 転移性癌20件の研究
- 大腸癌16件の研究
- 卵巣がん16件の研究
- 膵臓がん15件の研究
- 乳がん14件の研究
- 肺がん14件の研究
- 前立腺がん14件の研究
- 肝臓がん（肝細胞がん）14件の研究
- 急性骨髄性白血病13件の研究
- がん（全種類）13件の研究
- 胃癌13件の研究
ClinicalTrials.govより、2026/10/05時点のデータを取得。各研究には独自の参加資格があり、参加可否は研究チームが決定します。